ARDT β€” ARDENT HEALTH PARTNERS INC

Ownership history in RENAISSANCE TECHNOLOGIES LLC  Β·  3 quarters on record

This page tracks every 13F SEC filing in which RENAISSANCE TECHNOLOGIES LLC reported a position in ARDENT HEALTH PARTNERS INC (ARDT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

Position Intelligence

RENAISSANCE TECHNOLOGIES LLC Γ— ARDT AI Analytics

πŸ“‰ RENAISSANCE TECHNOLOGIES LLC underperformed the S&P 500 by –45.1% annually on this ARDT position. Average cost basis: $13.72. Maximum drawdown during holding period: –3.6%.

πŸ“ˆ Position Alpha vs SPY
-45.1%
annualised excess return

❌ Significantly underperformed the S&P 500 by 45.1% ann.
2 quarters analyzed

πŸ’° Entry Quality
$13.72
-3.4% vs current ($13.25)

Best entry: $13.66 (2025 Q2)  Β·  Worst: $13.75 (2025 Q1)

πŸ›‘οΈ Drawdown Resilience
–3.6%
max drawdown while held

πŸ’Ž No drawdown exceeding 20% during the holding period β€” exceptionally stable.

πŸ’ͺ Fund Conviction
67%
buy-side decisions

2 adds Β· 1 trim. Bought during 1 of 2 down-price quarters. πŸ“ˆ More buys than sells across the holding period.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.0% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    ARDT price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 3 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 10,700 -59,800 -84.8% 0.00% $142K $13.25
2025 Q2 ADDED 70,500 +24,800 +54.3% 0.00% $963K $13.66
2025 Q1 INITIATED 45,700 β€” β€” 0.00% $628K $13.75
← Back to RENAISSANCE TECHNOLOGIES LLC Holdings